Skip to main content
. 2019 Feb 27;4(1):e001209. doi: 10.1136/bmjgh-2018-001209

Figure 1.

Figure 1

Funding for neglected disease product development by sector, 2007–2016. Figure from Ref. 5. HICs, high-income countries; LMICs, low-income and middle-income countries; MNCs, multinational pharmaceutical companies; SMEs, small pharmaceutical and biotechnology firms.